Extra-cellular adenosine is an important regulator of inflammatory responses. It is generated from released ATP by a cascade of ectoenzymes and degraded by adenosine deaminase (ADA). There are two types of enzymes with ADA activity: ADA1 and ADGF/ADA2. ADA2 activity originates from macrophages and dendritic cells and is associated with inflammatory responses in humans and rats. Drosophila possesses a family of six ADGF proteins with ADGF-A being the main regulator of extra-cellular adenosine during larval stages. Herein we present the generation of a GFP reporter for ADGF-A expression by a precise replacement of the ADGF-A coding sequence with GFP using homologous recombination. We show that the reporter is specifically expressed in aggregating hemocytes (Drosophila immune cells) forming melanotic capsules; a characteristic of inflammatory response. Our vital reporter thus confirms ADA expression in sites of inflammation in vivo and demonstrates that the requirement for ADA activity during inflammatory response is evolutionary conserved from insects to vertebrates. Our results also suggest that ADA activity is achieved specifically within sites of inflammation by an uncharacterized post-transcriptional regulation based mechanism. Utilizing various mutants that induce melanotic capsule formation and also a real immune challenge provided by parasitic wasps, we show that the acute expression of the ADGF-A protein is not driven by one specific signaling cascade but is rather associated with the behavior of immune cells during the general inflammatory response. Connecting the exclusive expression of ADGF-A within sites of inflammation, as presented here, with the release of energy stores when the ADGF-A activity is absent, suggests that extra-cellular adenosine may function as a signal for energy allocation during immune response and that ADGF-A/ADA2 expression in such sites of inflammation may regulate this role.
Citation: Novakova M, Dolezal T (2011) Expression of Drosophila Adenosine Deaminase in Immune Cells during Inflammatory Response. PLoS ONE 6(3): e17741. https://doi.org/10.1371/journal.pone.0017741
Editor: Pankaj Kapahi, Buck Institute for Age Research, United States of America
Received: October 19, 2010; Accepted: February 10, 2011; Published: March 11, 2011
Copyright: © 2011 Novakova, Dolezal. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding was provided by KJB501410602, Grant Agency of the Academy of Sciences of the Czech Republic (http://www.gaav.cz/); 204/09/1463, Grant Agency of the Czech Republic (http://www.gacr.cz/); MSM6007665801, Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz/); and the Grant Agency of the University of South Bohemia (http://www.jcu.cz/research/gaju). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Extra-cellular adenosine is an important regulatory molecule with a low physiological concentration that can rapidly increase during tissue damage, inflammation, ischemia or hypoxia. In damaged tissues and inflammatory responses, extra-cellular adenosine is a product of ATP degradation, mediated by a cascade of ectoenzymes. Both ATP and adenosine stimulate purinergic receptors, and their release, signaling and progressive decrease regulate the onset of the acute inflammatory response, the fine-tuning of ongoing inflammation and its eventual down-regulation . However the overall regulation of inflammatory responses by ATP and adenosine is quite complex, especially in mammalian adaptive immunity, and thus many questions regarding the roles of ATP and adenosine persist.
An important step in this regulation is the degradation of adenosine by adenosine deaminase (ADA), an enzyme that converts adenosine and deoxyadenosine to inosine and deoxyinosine, respectively. Generally, two types of enzymes with the ADA activity are known; the ADA1 family proteins and adenosine deaminase-related growth factors (ADGF) or ADA2-like proteins. ADA1 is present both in prokaryotes and eukaryotes and has been studied for long time, mainly because its deficiency in humans causes severe combined immunodeficiency (SCID) syndrome. Although the most studied function of ADA1 is the reduction of toxic intracellular levels of adenosine, especially for lymphocytes , ADA1 has also been detected as an ectoenzyme associated with cell surface receptors .
Although ADA2 activity in human plasma was discovered long time ago , the protein responsible for this activity was only recently isolated . ADA2 (ENSG00000093072) is a secreted protein and adenosine seems to be its only substrate . ADA2 activity is significantly increased in the pleural effusions of tuberculosis patients  and the serum of patients infected with HIV . It was also shown that macrophages are the source of ADA2 activity during inflammatory responses in rats . Zavialov et al.  showed that ADA2 protein secreted by monocytes undergoing differentiation is the only source of ADA activity from these cells. They further revealed that human ADA2 promotes CD4+ T cell-dependent differentiation of monocytes to macrophages and their subsequent proliferation and that this role of ADA2 is independent of its ADA catalytic function.
ADA2 belongs to the family of ADGF proteins, first characterized in insect . The ADGF-A protein (FBgn0036752) from Drosophila melanogaster is similar to secreted human ADA2  and both proteins share all structure domains, including those considered unique to ADA2 . However, ADGF-A, as with other ADGFs from lower species, has a higher affinity for adenosine (similar to ADA1) than human ADA2. According to Zavialov et al. , human ADA2 may have become specialized during evolution to be an adenosine deaminase specifically active in sites of high adenosine concentration and lower pH, typified by sites of inflammation.
We have showed that ADGF-A mRNA is expressed in the Drosophila hematopoietic organ, called the lymph gland  and that this expression is required for larval survival . Drosophila hematopoiesis and cellular immunity are much simpler than in vertebrates, nevertheless both systems share many features . The main component of cellular immunity in flies is represented by plasmatocytes that are macrophage-like cells with phagocytic activity. These cells are responsible for the inflammatory response to tissue damage (clearance of tissue debris and healing) and infection. In similarity to vertebrate systems, these macrophage-like cells are attracted to sites of injury where they adhere and become phagocytic . This ability to recognize and adhere to damaged or “nonself” tissue is an ancestral feature of blood cells. In the case of larger objects, such as parasitic wasp eggs, specialized cells called lamellocytes (large flat cells) differentiate from prohemocytes and encapsulate the foreign object, thus isolating it from the rest of the body cavity. The intruding object is then destroyed by melanization; an important immune mechanism in arthropods utilizing toxic quinone substances and other short-lived reaction intermediates . These substances are also involved in the formation of more long-lasting products such as the melanin that physically encapsulates pathogens. Furthermore, reaction intermediates in the melanin pathway participate in the wound healing process by the formation of covalent links in damaged tissues and results in sclerotization.
Since hemocyte ADGF-A mRNA expression is required for larval survival, we were interested in the regulation of its expression. However, because there is no available antibody against ADGF-A, we decided to produce a vital GFP reporter for its expression using homologous recombination. Here we show that this reporter is expressed in vivo, in aggregating larval hemocytes at sites of inflammation and that the acute expression of the ADGF-A protein is most probably regulated at post-transcriptional level.
Materials and Methods
Drosophila strains and culture
The AGFP reporter was produced as described in File S1. The line depicted as AGFP, was used for the experiments presented herein; this line was kept as w; AGFP/TM6B and w; AGFP/TM3 Act>GFP Ser and crossed to the wild-type Oregon R strain to obtain AGFP/+. Additional lines used in this work were as following: Oregon-R as wild-type strain, w; adgf-akarel/TM6B, w; cactus[E8]/CyOGFP; AGFP/TM6B, w; cactus[IIIG]/CyOGFP, w; cactus[D13]/CyOGFP and y v hop[Tum]/FM7c. All flies were raised on corn meal/sucrose/agar medium and kept at 25°C.
w; AGFP/TM6B flies crossed to Oregon-R flies and only Oregon-R flies were left to lay eggs for 12 hours in regular food-containing vials. The second-instar larvae were then immunized by a parasitic wasp Leptopilina boulardi for two hours. The wasps were then discarded and the infected larvae permitted to continue their development for another 24–48 hours at 25°C. GFP fluorescence was then analyzed in encapsulated wasp eggs dissected from the third-instar larvae, as described below.
GFP fluorescence analysis
GFP fluorescence was analyzed in dechorionated embryos, whole and dissected larvae and pupae and in adult flies using fluorescent either stereomicroscopy and inverted microscopy. Hemocytes, melanotic capsules and parasitic wasp eggs were obtained by careful dissection of third-instar larvae in a drop of Ringer solution on a microscopic slide and immediately examined by one of fluorescent microscopic techniques. Samples were analyzed using differential interference contrast (DIC) and the Olympus U-MWG2 GFP filter settings. Micrographs were obtained using a color CCD, Olympus DP70 camera.
Expression analysis by RT-PCR and Real-time PCR
Total RNA was isolated using TRI Reagent (Molecular Research Center, Cincinnati, Ohio) according to manufacturer's instructions. RNA was isolated from w; AGFP/TM3 Act>GFP Ser stock in the following hours after egg laying: 14–18 h (embryos), 34–38 h (first-instar larvae), 58–62 h (second-instar larvae), 82–86 h (third-instar larvae) and from the third-instar wandering larvae, white prepupae, pupae 26–34 h after pupation and three days-old adult males and females. cDNA was generated from 2.4 µg of RNA treated with TURBO DNase I (Ambion, Austin, TX) using the SuperScript III Reverse Transcriptase kit (Invitrogen, Carlsbad, CA) with oligo(dT) primering. Actin amplification was used to determine the final dilution of cDNA from each sample for the PCR reactions which were performed using the following primers: 5′-TACCCCATTGAGCACGGTAT-3′ and 5′-GGTCATCTTCTCACGGTTGG-3′ for Actin, 5′-AATCGGAGCTCCTCAATCGC-3′ and 5′-GCTACACATTGATCCTAGC-3′ for AGFP, 5′-AGGTTCTCATCCACAGTGG-3′ and 5′-CGGACTACTACTACAAAGC-3′ for ADGF-A.
Third-instar wandering larvae of the following genotypes were used for Real-time PCR analysis: AGFP/+, AGFP/AGFP, cactus[IIIG]/cactus[E8]; AGFP/+, cactus[D13]/cactus[E8]; AGFP/+. Total RNA was isolated (1) from 60 whole larvae using TRI Reagent and (2) from hemocytes as follows: 15–30 larvae were dissected one at a time in Ringer solution in 1.5-ml tubes and the hemolymph collected (the remaining body was discarded). The hemolymph were then centrifuged for 5 min at 1500×g, the supernatant discarded and total RNA isolated from the collected hemocytes using the RNAqueous-Micro kit (Ambion, Austin, TX). The RNA was then treated with TURBO DNase I. The concentration of RNA was determined by NanoDrop ND1000 (Thermo Fisher Scientific Inc., Waltham, MA) analysis and cDNA synthesized using the SuperScript III Reverse Transcriptase kit with oligo(dT) primering. The cDNA was then treated with RNaseH (Takara, Japan). Samples were analyzed by Real-time PCR using 1× Syber green Supermix (Biorad, Hercules, CA) and 5 pmol of each primer in CFX96 Real Time System C1000 (Biorad) as triplicate measurements. The following primers were used: 5′-CTTCATCCGCCACCAGTC-3′ and 5′-CACGTTGTGCACCAGGAA-3′ for Rp49, 5′-GGATCCCCCAGTCAACGG-3′ specific for ADGF-A, 5′-TGCTTCTGCTAGGATCAATGTGTA-3′ specific for AGFP and 5′-CTGAGTGGATGCGAATGAGAGTG-3′ common for ADGF and AGFP. Biorad CFX Manager software was used to quantify transcript levels by comparison to relative standard curves generated for each gene by serial (5×) dilutions of Drosophila genomic DNA. Levels of ADGF-A and AGFP were normalized with Rp49 levels from the same cDNA samples and plotted as ADGF-A or AGFP expression level relative to Rp49. Results are shown as mean ± SEM of three independent experiments. The experimental significance was determined using a Student's t test utilizing the STATISTICA 6 software (StatSoft) package.
Generation of the ADGF-A reporter system
We used homologous recombination to produce a GFP reporter for the analysis of endogenous, in vivo, levels of ADGF-A expression by the precise replacement of the ADGF-A coding sequence with that of GFP (Figure 1). This therefore ensured that all the surrounding regulatory sequences, including 5′ and 3′ untranslated regions, of ADGF-A locus remained intact. We utilized a destabilized version of the Green Fluorescent Protein (dGFP) , that makes it possible to analyze dynamic changes in ADGF-A expression since the dGFP does not accumulate in cells as it is turned-over in around 2–4 hours.
The arrangement of three ADGF genes on the wild-type chromosome III is shown on the top. The bottom panel shows gene organization in the reporter system. Coding sequences are depicted by dark boxes and white boxes indicate 5′ and 3′ untranslated regions of the genes. Introns are represented by chevron-shaped lines, intergenic spaces by horizontal lines. Dashed lines depict the replacement. 5′-3′ orientation of all three genes is shown from left to right. The ADGF-A gene shares the first exon with the ADGF-A2 gene but it also uses an alternative transcription start site, specific only for the ADGF-A gene marked by an arrow. XhoI restriction sites in the sequence are depicted by triangles and the fragment lengths after the digestion are shown above each sequence in kilobases.
We used the ‘ends-in’ version of homologous recombination  that permitted precise exchange of the coding sequences in two steps and without leaving any traces of the recombination process. The first recombination step produced a duplication in the ADGF-A containing region, with the ADGF-A coding sequence at one side and the dGFP coding sequence on the other side (File S1). The second recombination step resulted in a reduction (File S1) of this configuration, thus producing the sequence assembly as shown in Figure 1. Details of the whole procedure are described in File S1.
We obtained a total 12 lines exhibiting the correct replacement as judged by the successful hybridization of the dGFP probe to DNA fragments of correct size in Southern blotting analysis (Figure 2). We named this replacement as AGFP (for ADGF-A GFP reporter). The Southern blot results were further confirmed by PCR and sequencing (data not shown). In two lines (8-4 and 74-3; Figure 2), the second recombination event occurred downstream of the ADGF-A/dGFP sequences restoring a wild-type gene arrangement (File S1). This was confirmed by PCR analysis resulting in an amplification of the ADGF-A fragment size instead of the shorter dGFP sequence (data not shown).
Genomic DNA was digested with XhoI restriction enzyme and the membrane was hybridized with the dGFP probe. The size of the XhoI fragment hybridised with the dGFP probe, after the successful replacement is 7.7 kb (Figure 1 and File S1) - the DXI line with duplication was used as a control for the fragment size (File S1). Sizes in kilobases are depicted above each band of the DIG-labeled marker.
Since the replacement of the ADGF-A coding sequence results in a null mutation of this gene we examined the homozygous AGFP or heterozygous adgf-a/AGFP larvae and found that they exhibited the same phenotype as the originally described adgf-a mutant  (see further); thus providing confirmation at the phenotypic level that the replacement successfully occurred within the ADGF-A locus.
Expression of AGFP mRNA
Our molecular characterization (Figure 2 and File S1) confirmed that the coding sequence of the ADGF-A gene had been accurately replaced by the coding sequence of dGFP. Therefore, we further analyzed if the expression of AGFP reporter mRNA corresponded to the endogenous ADGF-A expression.
ADGF-A mRNA is normally expressed throughout all stages of development  (Figure 3) and similarly, the AGFP mRNA was also expressed at all stages (Figure 3). This demonstrated that our AGFP reporter expression system was able to faithfully report the temporal expression of the endogenous ADGF-A gene.
The total RNA was isolated from w; AGFP/TM3 Act>GFP Ser individuals at the following stages: embryos (E), first-instar larval stage (L1), second-instar larval stage (L2), third-instar larval stage (L3), wandering larvae (W), prepupae (PP), pupae (P), male adults (M) and female adults (F). RNA was reverse transcribed and amplified by PCR using ADGF-A or AGFP specific primers. Actin cDNA was amplified as template control.
Moreover Figure 4A demonstrates that the overall levels of mRNA are similar (p = 0,286) for both ADGF-A and AGFP transcripts when measured in samples obtained from the AGFP/+ heterozygous wandering larvae; where ADGF-A is expressed from wild-type chromosome and AGFP from the modified one.
(A) Expression level in whole larvae and (B) circulating hemocytes. (C) Combined expression in whole larvae and in hemocytes plotted on one graph to demonstrate the difference in levels. Data represent mean values ± SEM, normalized relative to the endogenous control.
We had previously shown that the expression of ADGF-A in the larval hematopoietic system is crucial for larval survival . In agreement with this observation, Figure 4C demonstrates that the expression of ADGF-A in larval hemocytes is ∼10 times stronger compared to overall larval expression. This cell type-specific expression pattern is also represented in the expression of the AGFP reporter (Figure 4B, p = 0,344), further confirming the fidelity of the created reporter system in relaying the normal pattern of endogenous ADGF-A expression.
ADGF-A expression analysis by the AGFP reporter
Utilizing our AGFP reporter we analyzed the in vivo ADGF-A expression by observing the fluorescence of dGFP in the AGFP/+ animals at all developmental stages. Surprisingly, we did not detect any fluorescence above background levels in any tissue/cells (data not shown), including larval hemocytes where we could detect mRNA in relatively high quantities. We examined several independent versions of our reporter line, including AGFP and AGFP, that were analyzed thoroughly (data not shown).
We also tried to detect the dGFP protein in fixed AGFP/+ embryos and larvae by immuno-fluorescence using an anti-GFP antibody. We hoped this would overcome both the background autofluorescence that is close to the green spectrum (by using secondary antibody conjugated to the red flourophore, Cy3) and potentially low levels of dGFP protein present by signal amplification achievable using a polyclonal antibody. We also tried to detect the dGFP protein in whole larval and hemocyte lysates by western blotting. However, we were unable to detect the dGFP protein by any of these methods (data not shown), suggesting that there is either no expression of the AGFP reporter or that expression levels fall below our detection thresholds.
Interestingly, we did detect GFP fluorescence in aggregating hemocytes of AGFP homozygous animals (Figure 5B,D,F). AGFP homozygotes are effectively adgf-a gene mutants and thus present the same mutant phenotype that includes melanotic capsule formation associated with differentiating hemocytes . The strongest GFP expression was detected in the melanotic capsules (Figure 5F). These capsules are formed by aggregating plasmatocytes and lamellocytes, with inside melanization. While most of the circulating, i.e. non-adhered plasmatocytes and lamellocytes did not express GFP (Figure 5C), the aggregating cells did (Figure 5B). This was especially apparent in large aggregates (Figure 5D) that eventually formed melanized capsules (Figure 5F).
(A) Aggregating lamellocytes from the adgf-a mutant larvae without AGFP as a control to account for autofluorescence. (B) Aggregating lamellocytes from AGFP homozygotes showing GFP fluorescence. (C) Non-aggregating plasmatocytes and lamellocytes from AGFP homozygotes that rarely displayed any GFP fluorescence. (D) A clump of plasmatocytes and lamellocytes from AGFP homozygotes exhibiting strong GFP expression. (E) A melanotic capsule from the adgf-a mutant showing only yellowish autofluorescence of the melanized region. (F) GFP fluorescence in hemocytes surrounding a melanotic capsule from AGFP homozygotes. (G) A melanotic capsule from the null cactus mutant with AGFP reporter (cactus[E8]/cactus[D13]; AGFP/+) showing GFP expression in surface lamellocytes. (H) A melanizing clump with lamellocytes and plasmatocytes expressing GFP in hopTum; AGFP/+ mutant. Scale bar (50 µm) is shown in white on DIC images. Genotypes are shown on corresponding fluorescent micrographs distinguished with an apostrophe. All fluorescent images were captured using the same exposure settings.
It was possible that this observed fluorescence was due to an increased expression of AGFP mRNA in adgf-a deficient, AGFP homozygous larvae. Therefore we measured AGFP mRNA levels in AGFP homozygous and heterozygous larvae and hemocytes. We did not detect any significant differences in mRNA levels (P = 0,286 for larvae and p = 0,45 for hemocytes, respectively) between homozygotes and heterozygotes (heterozygotes levels were doubled due to a presence of only one AGFP allele) (Figure 6A,B). It is important to note that there was quite high variability in the mRNA levels of homozygotes most likely attributable to variability in the mutant phenotype. This is because development was quite delayed making it difficult to collect larvae at precisely the same stage. More valuable results for comparison were obtained using cactus mutants (see below).
(A) Expression in hemocytes and (B) in wandering larvae. Data represent the mean values ± SEM, normalized relative to the endogenous control. The following genotypes are shown: AGFP/+, AGFP/AGFP, cactus[D13]/cactus[E8]; AGFP/+ and cactus[IIIG]/cactus[E8]; AGFP/+. Columns indicated by asterisks are significantly different from AGFP/+ control (hemocytes: p(AGFP/AGFP) = 0,45; p(D13/E8) = 0,27; p(IIIG/E8) = 0,45; larvae: p(AGFP/AGFP) = 0,2862; p(D13/E8) = 0,00028; p(IIIG/E8) = 0,0063).
AGFP expression in cactus mutants
The melanotic capsule phenotype of the adgf-a mutant is similar to another phenotype caused by the constitutive activation of Toll signaling . This can be achieved by a zygotic mutation in the Cactus gene (FBgn0000250), an inhibitor of the Rel transcription factors Dorsal and Dif, that activate Toll target genes. Therefore we tested if cactus mutations would lead to the expression of our AGFP reporter.
Similarly to AGFP homozygous larvae, both hypomorphic (cactus[E8]/cactus[IIIG]) and null (cactus[E8]/cactus[D13]) mutant combinations  together with AGFP/+ showed GFP fluorescence in aggregating hemocytes and especially in the outer border of melanotic capsules (data not shown and Figure 5G). Since this result was obtained in AGFP/+ heterozygotes, it demonstrated that it was not the adgf-a mutant phenotype, nor the presence of two AGFP copies that are required for AGFP reporter expression. Rather it was the behavior of hemocytes and particularly their aggregation that causes the expression of dGFP protein.
We also assayed the AGFP mRNA levels in the cactus mutant background. We did not detect significant changes in AGFP mRNA expression when comparing hemocytes with and without cactus mutations (Figure 6A). When the AGFP levels were compared in whole larvae, the amount was however increased in the cactus mutants (Figure 6B). Since we did not observe GFP expression in any other cells/tissues of the cactus mutants, besides the hemocytes, this difference was most likely caused by the increased number of hemocytes per larva in the cactus mutants .
AGFP expression in hopTum mutant
The hopTum mutation (FBal0005547) results in the hyperactivity of the Jak kinase Hopscotch , leading to the aggregation of hemocytes and the formation of melanotic capsules. In similarity to AGFP homozygotes and cactus mutants, hopTum mutants also promote the expression of the AGFP reporter in hemocyte aggregates that were forming melanotic capsules (Figure 5H).
AGFP expression in larvae infected by parasitic wasps
As we know that the AGFP reporter was expressed in larvae harboring different mutations that induced melanotic capsule formation, we used a parasitic wasp Leptopilina boulardi to test its expression during a real immune challenge that would result in melanotic capsule formation. When the parasitic wasps lay their eggs in Drosophila larvae, the plasmatocytes attach themselves to the surface of the egg and thereafter the egg is encapsulated by lamellocytes and destroyed by melanization . We found that the AGFP reporter started to produce a dGFP signal during the encapsulation process (Figure 7B) and it was strongly expressed in fully encapsulated and melanized eggs (Figure 7C). This result revealed that our AGFP reporter system was able to inform us as to the in vivo expression of ADGF-A status in response to a bona fide immune challenge within a living animal.
(A) Partially encapsulated wasp eggs from Oregon-R larva as a control displaying only yellow auto-fluorescence of the wasp eggs. (B) Partially encapsulated wasp egg from AGFP/+ larva showing a faint but clearly visible green fluorescence of AGFP reporter in the encapsulating lamellocytes. (C) A fully encapsulated and melanized wasp egg from AGFP/+ larva exhibitting strong AGFP expression in the encapsulating material. DIC (top with 100-µm black scale bar) and corresponding fluorescence (bottom labeled by letter plus an apostrophe) images are shown in each panel.
Generation and verification of reporter
The adenosine deaminase activity of ADGF-A is an important regulator of extra-cellular adenosine in Drosophila larvae . Therefore we decided to make a vital GFP reporter system which would allow us to observe dynamic changes in the ADGF-A expression in vivo.
This work demonstrated that it was possible to use the ‘ends-in’ based method of homologous recombination  to specifically and precisely replace a target gene sequence with that of a reporter (or other heterologous sequence). We used this approach to precisely exchange the entire coding-sequence of the ADGF-A gene with that of the dGFP reporter, leaving intact all the regulatory sequences, including the whole 5′ and 3′ UTRs, of the locus. This allowed us to faithfully reproduce the natural expression pattern of ADGF-A in a manner offering maximal fidelity, especially when compared with more conventional methods of transgenic reporter fly generation that rely on random sites of genomic integration.
Our molecular and phenotypic characterizations of recombination events, coupled with the developmental and the hemocyte-specific expression profiling clearly demonstrated the successful creation of the reporter. Furthermore that it faithfully recapitulates the expression pattern of the endogenous ADGF-A. Although newer, and arguably less laborious, strategies to target genes  or to tag proteins utilizing novel recombineering strategies  are now becoming available, it is important to note that our reporter does represents the first faithful reporter of ADGF-A expression to be published. We anticipate that this will be of use to the wider Drosophila community, especially in light of the absence of anti-ADGF-A antiserum.
Although reporter-derived AGFP mRNA was present in all developmental stages (and in similar levels to the endogenous ADGF-A transcripts), we did not detect any GFP protein expression at any developmental stage under normal growth conditions. This may be because the expression levels were too low to be detectable using the available methodology. Additionally in the case of heterozygous animals, the reporter was only expressed from one of the two alleles, thus lowering the potentially detectable expression to ∼50% compared to normal endogenous ADGF-A expression. However, the detectable GFP fluorescence only at the sites of hemocyte aggregation in both AGFP homozygous and heterozygous animals suggests that heterozygosity of the reporter was not the reason. We also used a destabilized version of GFP that is reported to undergo degradation within a couple hours . Whilst this allowed us to observe the important dynamic changes in ADGF-A expression, it probably also lowered the overall reporter signal and as a consequence its sensitivity, especially when compared with more stable GFP variants. Therefore we can not conclude that there is no expression of ADGF-A/AGFP at the protein level under normal growth conditions but rather if there is any expression, it is certainly very low.
Expression of reporter in site of inflammation
In agreement with the previously reported expression of ADGF-A mRNA in the hematopoietic organ , we found that the ADGF-A/AGFP mRNA was quite abundant in hemocytes under normal physiological conditions; typified by circulating and sessile non-activated macrophage-like cells called plasmatocytes. Nevertheless, we rarely observed GFP fluorescence in these cells. However we found that GFP expression was induced in hemocytes during the formation of melanotic capsules, a type of immune response typical of insects . The purpose of melanization is to either isolate and destroy larger foreign bodies that are too big to be phagocytosed or its involvement in the healing of larger wounds. Melanotic capsule formation can be considered a form of inflammatory response since it involves the recruitment and adherence of immune cells (including the macrophage-like plasmatocytes and specialized insect cells called lamellocytes) to large invading objects, as required. Furthermore, both plasmatocytes and lamellocytes expressed the AGFP reporter as they became adhesive and especially in the site of melanotic capsule formation, i.e. the site of inflammation.
We used four different ways to induce melanotic capsule formation in larvae. Firstly, in the adgf-a mutant, it was induced by a disintegration of endogenous larval tissue, the fat body , . Secondly, in the cactus mutant, it was induced by constitutive activation of Toll signaling leading to lamellocytes differentiation and the spontaneous aggregation of both plasmatocytes and lamellocytes with consequent melanotic capsule formation . Thirdly, in the hopTum mutant, hyperactivation of the JAK/STAT signalling cascade led to melanotic capsule formation . Lastly, melanotic capsule formation was induced by a genuine immune reaction to an egg deposited by a parasitic species of wasp. This last approach demonstrated that the observed AGFP reporter expression did not occur as a consequence of the genetic manipulations used in the other three cases, but rather was indicative of a bona fide, in vivo immune response. In all four cases the AGFP reporter was only expressed in the adherent hemocytes of the melanotic capsule, thus indicating that the ADGF-A protein expression is tightly associated with hemocyte function during the immune reaction regardless of the inducing factor and signaling cascades involved.
Is ADGF-A expression post-transcriptionally regulated?
We did not detect any significant increases in AGFP mRNA levels in hemocytes isolated from larvae forming melanotic capsules (and expressing abundantly detectable GFP fluorescence), when compared to hemocytes from AGFP/+ larvae with no melanotic capsules (and exhibiting a lack of GFP fluorescence). In addition, the ADGF-A/AGFP mRNA was quite abundant in these unchallenged wild-type hemocytes, corresponding to ∼10% of the mRNA levels of the ribosomal house-keeping protein gene, Rp49. These results suggest the possibility of a post-transcriptional regulative mechanism of ADGF-A/AGFP protein expression. It should be stressed that both 5′ and 3′ UTRs of the ADGF-A mRNA were preserved in the AGFP reporter mRNA; only the coding sequence was replaced. Therefore, the potential for adgf-a gene UTR-mediated post-transcriptional regulation of the GFP reporter sequence exists. Since adenosine is readily transported across the plasma membrane by nucleoside transporters , an intriguing possibility may be provided by the potential for a riboswitch mechanism, similar to that present in prokaryotic adenosine deaminase based regulation . Riboswitches have mostly been described as mechanisms of bacterial regulation that enable rapid responses to environmental stimuli. They typically act via the binding of specific ligands (e.g. purine molecules) to riboswitch regulatory elements in 5′ UTR of mRNA's, thus prompting or inhibiting their translation. It is therefore possible that when hemocytes find themselves in environments of high concentrations of extra-cellular adenosine, they take the adenosine up and it then binds to a riboswitch within the 5′ UTR of the ADGF-A mRNA, that subsequently activates the translation of the ADGF-A protein. Accordingly, we did observe increases in the expression of our AGFP reporter system, when isolated but non-adhered hemocytes were challenged by a dose of exogenous adenosine (data not shown). However we were unable to obtain quantifiable data due to the inherently weak AGFP signal in our system. Furthermore, it is also possible that the activation or adherence of hemocytes also play a role in this regulation that we are unable to yet model. Nevertheless, it will be very important to further explore the mechanism of this post-transcriptional regulation evidently at work in our system and investigate whether a similar mechanism is also operating in mammalian systems.
What is the role of ADGF/ADA2 in the site of inflammation?
There are at least two ways ADA2 can influence the inflammatory response. Firstly, by its catalytic-independent signaling function and secondly, via regulating adenosine levels through its adenosine deaminase enzymatic activity. It is not known if Drosophila ADGF-A exerts a signaling function similar to human ADA2. This function might be an evolutionary adaptation in vertebrates since the signaling function is associated with adaptive immunity  and includes cells that are not present in the innate immunity of Drosophila. Interestingly, insect wounds do not undergo the same burst of cellular proliferation and differentiation that characterizes mammalian wounds healing . However, ADGF-A does shares all the protein domains, including the putative receptor binding domain, with human ADA2  and thus the potential signaling role of ADGF proteins in insects should to be addressed.
The role of ADGF/ADA2 in the site of inflammation is certainly linked to its catalytic activity (the conversion of extra-cellular adenosine to inosine). There are at least two important roles of extra-cellular adenosine during inflammatory response; to mitigate the severity of the potentially harmful response by its anti-inflammatory role and to readjust the energy ‘supply-to-demand’ ratio by stimulating additional blood flow and glucose release from stores.
Changes in the relative amounts of ATP and adenosine form the core of inflammatory response regulation, and act through the purinergic receptors . The release of ATP into the extra-cellular space acts a potently pro-inflammatory, ‘danger-associated molecular pattern’ (DAMP) signal. Such inflammatory processes are associated with a significant increase in the expression of ecto-5′nucleotidase that acts to rapidly convert ATP into adenosine . Furthermore, in vertebrates, adenosine itself is a strongly anti-inflammatory molecule  and acts later to down-regulate inflammation. Therefore during acute inflammation, increased extra-cellular adenosine is rapidly metabolized to inosine by adenosine deaminase. Indeed, a close correlation can be observed between inflammation and local increases in adenosine deaminase activity , . Our results in Drosophila confirm this correlation in vivo and suggest that adenosine plays a similar role during the inflammatory response of insects as in vertebrates.
However, lowering extra-cellular adenosine levels may have an important function beyond the site of inflammation. Extra-cellular adenosine is traditionally regarded as a local signal due to its usually rapid metabolism; therefore only exerting localized effects on cells/tissues surrounding its site of production. However, studies in the rat model suggest it can act over longer distances in a hormone-like manner . In this rat model, lower-limb ischemia causes the muscular accumulation of both extra-cellular adenosine and inosine that upon reperfusion are rapidly released into the circulating blood. It is these plasma nucleosides that then promote hepatic glucose release and eventual hyperglycemia, via the activation of A3 adenosine receptor on hepatocytes. We recently demonstrated that extra-cellular adenosine can also act as an anti-insulin hormone stimulating a release of glucose from stores in the Drosophila model . Therefore a connection between the work presented here (demonstrating the quite exclusive expression of ADGF-A in sites of inflammation) and our previous study (showing the hyperglycemic effect caused by the deficiency of ADGF-A associated with increased extra-cellular adenosine ) could lead to a reappraisal of the roles of extra-cellular adenosine and its regulation by ADGF-A/ADA2. Accordingly, damaged tissues and sites of inflammation generating significant amounts of extra-cellular adenosine, may serve as sites of hormone production that alert an organism towards the appropriate allocation of energy reserves towards mounting a necessary immune reaction. Such a mechanism would need to be under tight control as not to precipitate harmful hyperglycemia and eventually uncontrolled loss of energy reserves. Therefore, once the stimulus for the inflammation is under control, marked by the presence of sufficient activated immune cells at the inflammation site, the signal for energy release should be suppressed. This could explain why ADGF-A protein is only expressed in fully adhered immune cells at site of inflammation i.e., to dampen this important but potentially dangerous signal. The deficiency of ADGF-A protein that causes hyperglycemia and progressive loss of energy reserves in flies  illustrates the potential importance of this regulatory circuit. The ability of extra-cellular adenosine to stimulate glucose release over longer distances  and the expression of ADA2 in sites of inflammation ,  suggest that similar roles of adenosine and ADA2 in energy allocation could be applicable to mammalian systems.
To better understand the immunomodulatory roles of ATP and adenosine it is important to monitor dynamic changes in the expression of their receptors and the enzymes regulating their in vivo concentrations. This is especially applicable in a time when increasing attention is being paid to the role of adenosine system in inflammation and its involvement in, for example, the pathophysiology of inflammatory bowel diseases . Our work demonstrates that Drosophila could serve as a valuable and convenient model for visualization of such dynamic changes an in vivo context.
Our work reports the creation of a functional in vivo expression reporter for ADGF-A using precise gene replacement homologous recombination procedures. Results of this work confirm the expression of ADGF/ADA2 enzymes in the site of inflammation by showing that ADGF-A expression occurs specifically in the adhered immune cells of such sites in Drosophila. This supports the view that the inflammatory response and its regulation are evolutionary ancient and Drosophila and mammalian systems share common mechanistic features. Our model also suggests that the expression of adenosine deaminase during inflammation response might be regulated at post-transcriptional level, therefore potentially providing a means of rapid responding regulation. Our previously uncharacterised observations of ADGF-A expression highlight its potential regulatory role in energy allocation stimulated by extra-cellular adenosine.
We thank Tamas Lukacsovich, Kent Golic and Yikang Rong for providing us with all fly strains and plasmids for this work. We are especially grateful to Katerina Kucerova for her care of flies and laboratory management associated with this work. We would also like to thank Michele Crozatier and her lab where the experiments with parasitic wasps were performed and David Dolezel for help with Real-Time PCR.
Conceived and designed the experiments: MN TD. Performed the experiments: MN. Analyzed the data: MN TD. Contributed reagents/materials/analysis tools: TD. Wrote the paper: MN TD.
- 1. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC (2006) Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112(2): 358–404.
- 2. Aldrich MB, Blackburn MR, Kellems RE (2000) The importance of Adenosine deaminase for lymphocyte development and function. Biochem Biophys Res Commun 272: 311–315.
- 3. Franco R, Casado V, Ciruela F, Saura C, Mallol J, et al. (1997) Cell surface adenosine deaminase: much more than an ectoenzyme. Prog Neurobiol 52: 283–294.
- 4. Ratech H, Thorbecke GJ, Meredith G, Hirschhorn R (1981) Comparison and possible homology of isozymes of adenosine deaminase in Aves and humans. Enzyme 26(2): 74–84.
- 5. Zavialov AV, Engström A (2005) Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity. Biochem J 391(Pt 1): 51–57.
- 6. Niedzwicki JG, Abernethy DR (1991) Structure-activity relationship of ligands of human plasma adenosine deaminase2. Biochem Pharmacol 41(11): 1615–1624.
- 7. Valdés L, Pose A, San José E, Martinez Vázquez JM (2003) Tuberculous pleural effusions. Eur J Intern Med 14(2): 77–88.
- 8. Niedzwicki JG, Mayer KH, Abushanab E, Abernethy DR (1991) Plasma adenosine deaminase2 is a marker for human immunodeficiency virus-1 seroconversion. Am J Hematol 37(3): 152–155.
- 9. Conlon BA, Law WR (2004) Macrophages are a source of extra-cellular adenosine deaminase-2 during inflammatory responses. Clin Exp Immunol 138(1): 14–20.
- 10. Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, et al. (2010) Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol 88(2): 279–290.
- 11. Homma K, Matsushita T, Natori S (1996) Purification, characterization, and cDNA cloning of a novel growth factor from the conditioned medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina (flesh fly). J Biol Chem 271: 13770–13775.
- 12. Zurovec M, Dolezal T, Gazi M, Pavlova E, Bryant PJ (2002) Adenosine deaminase-related growth factors stimulate cell proliferation in Drosophila by depleting extra-cellular adenosine. Proc Natl Acad Sci USA 99: 4403–4408.
- 13. Zavialov AV, Yu X, Spillmann D, Lauvau G, Zavialov AV (2010) Structural basis for the growth factor activity of human adenosine deaminase ADA2. J Biol Chem 285(16): 12367–12377.
- 14. Dolezal T, Dolezelova E, Zurovec M, Bryant PJ (2005) A role for adenosine deaminase in Drosophila larval development. Plos Biol 3: e201.
- 15. Evans CJ, Hartenstein V, Banerjee U (2003) Thicker than blood: conserved mechanisms in Drosophila and vertebrate hematopoiesis. Dev Cell 5(5): 673–690.
- 16. Babcock DT, Brock AR, Fish GS, Wang Y, Perrin L, et al. (2008) Circulating blood cells function as a surveillance system for damaged tissue in Drosophila larvae. Proc Natl Acad Sci U S A 105(29): 10017–10022.
- 17. Cerenius L, Lee BL, Söderhäll K (2008) The proPO-system: pros and cons for its role in invertebrate immunity. Trends Immunol 29(6): 263–271.
- 18. Li X, Zhao X, Fang Y, Jiang X, Duong T, et al. (1998) Generation of destabilized green fluorescent protein as a transcription reporter. J Biol Chem 273: 34970–34975.
- 19. Rong YS, Golic KG (2000) Gene targeting by homologous recombination in Drosophila. Science 288: 2013–2018.
- 20. Qiu P, Pan PC, Govind S (1998) A role for the Drosophila Toll/Cactus pathway in larval hematopoiesis. Development 125: 1909–1920.
- 21. Harrison DA, Binari R, Nahreini TS, Gilman M, Perrimon N (1995) Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J 14(12): 2857–2865.
- 22. Lanot R, Zachary D, Holder F, Meister M (2001) Postembryonic hematopoiesis in Drosophila. Dev Biol 230(2): 243–257.
- 23. Rong YS, Golic KG (2001) A targeted gene knockout in Drosophila. Genetics 157: 1307–1312.
- 24. Carroll D, Beumer KJ, Morton JJ, Bozas A, Trautman JK (2008) Gene targeting in Drosophila and Caenorhabditis elegans with zinc-finger nucleases. Methods Mol Biol 435: 63–77.
- 25. Ejsmont RK, Sarov M, Winkler S, Lipinski KA, Tomancak P (2009) A toolkit for high-throughput, cross-species gene engineering in Drosophila. Nat Methods 6(6): 435–437.
- 26. Zuberova M, Fenckova M, Simek P, Janeckova L, Dolezal T (2010) Increased extra-cellular adenosine in Drosophila that are deficient in adenosine deaminase activates a release of energy stores leading to wasting and death. Dis Model Mech 3(11–12): 773–784.
- 27. Sankar N, Machado J, Abdulla P, Hilliker AJ, Coe IR (2002) Comparative genomic analysis of equilibrative nucleoside transporters suggests conserved protein structure despite limited sequence identity. Nucleic Acids Res 30: 4339–4350.
- 28. Rieder R, Lang K, Graber D, Micura R (2007) Ligand-induced folding of the adenosine deaminase A-riboswitch and implications on riboswitch translational control. Chembiochem 8(8): 896–902.
- 29. Galko MJ, Krasnow MA (2004) Cellular and genetic analysis of wound healing in Drosophila larvae. PLoS Biol 2(8): E239.
- 30. Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, et al. (2008) Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases. Inflamm Bowel Dis 14(4): 566–574.
- 31. Cortés D, Guinzberg R, Villalobos-Molina R, Piña E (2009) Evidence that endogenous inosine and adenosine-mediated hyperglycaemia during ischaemia-reperfusion through A3 adenosine receptors. Auton Autacoid Pharmacol 29(4): 157–164.